시장보고서

상품코드

1997067

약물전달 기기 수탁제조 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 범위 - 디바이스 유형별, 서비스 유형별, 지역별

Drug Delivery Devices Contract Manufacturing Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Device Type, Service Type, and Geography

발행일: 2026년 02월 | 리서치사: 구분자

The Insight Partners | 페이지 정보: 영문 198 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

The Insight Partners의 새로운 조사 보고서 '약물전달 기기 수탁제조 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 범위 - 디바이스 유형별, 서비스 유형별, 지역별'에 따르면, 이 시장은 2025년 82억 4,000만 달러에서 2034년까지 217억 2,000만 달러 규모로 성장할 것으로 예상되며, 2026년부터 2034년까지 까지 연평균 성장률(CAGR)은 11.5%를 나타낼 것으로 예측됩니다. 약물 전달 장치 수탁제조 시장의 성장은 만성 질환의 유병률 증가, 기술 발전과 혁신, 아웃소싱을 통한 비용 효율성 증가에 기인합니다.

약물전달 기기 설계, 개발, 생산을, 이러한 분야를 전문으로 하는 수탁 개발 제조 기관(CDMO)에 아웃소싱 하는 것으로, 제약회사나 바이오테크놀러지 기업은 엔드 투 엔드 생산 공정 전체를 관리하는 제삼자 제조업체가 제공하는 경험, 전문 지식, 기술력, 규모의 경제 성을 활용하면서, 자사 코어 컨피턴스(competence)인 약제 개발, 연구개발 및 상업화에 주력 할 수 있습니다.이것에는 부품 제조, 조립, 품질 보증, 시험, 규제 준수 및 포장이 포함됩니다.제조 AI나 디지털 기술 도입, 지속가능으로 친환경 제조 관행에의 중점화, 그리고 개별화·환자 중심 전달 시스템 부상은 향후 몇 년간 의약품 전달 디바이스 수탁제조 시장 주요 동향으로서 부상할 것으로 예측됩니다.

북미 약물전달장치 위탁생산 시장은 미국, 캐나다, 멕시코로 구분됩니다. 북미의 약물 전달 장치 위탁생산 시장은 미국에만 400개 이상의 정밀 엔지니어링 및 규제 준수에 중점을 둔 클래스 II 및 III 장치 전문 시설이 존재하며, 북미에는 많은 시설이 존재하기 때문에 시장이 확대되고 있습니다. 시장 점유율은 미국이 가장 크고, 그 다음이 캐나다입니다.

미국에만 400개 이상의 전문 시설이 있으며, 정밀 엔지니어링, 규제 준수 및 주사제, 흡입기, 경피 투여 시스템용 신기술 개발에 중점을 두고 클래스 II 및 클래스 III 의료기기 제조를 전문으로 하는 전문 시설이 400개 이상 있습니다. Catalent와 같은 주요 기업들은 자동 인젝터 및 펜형 인젝터 조립을 위한 여러 시설을 운영하고 있습니다. 인티저홀딩스는 주입 펌프의 조립 서비스를 제공하고 있으며, 대량 생산을 필요로 하는 고객의 요구에 부응하기 위해 신속하게 생산 체제를 확대할 수 있습니다. 미국 질병예방통제센터(CDC)가 최근 발표한 자료에 따르면, 심혈관 및 정형외과용 투여장치의 아웃소싱은 미국 성인 당뇨병 환자 수 증가(3,400만 명 이상)에 힘입어 2020년까지 연평균 11.4%의 성장률을 보일 것으로 예측됩니다. 의료기기 제조에 종사하는 총 직원수는 100만 명을 넘어섰으며, 자동화의 발전으로 불량률이 20% 감소했습니다.

공급망의 혼란으로 인해 시장 출시 기간까지 15%의 영향이 발생했습니다. 이는 FDA를 통한 'Case for Quality(CfQ)'이니셔티브에서 채택된 방법론에 기인합니다. 'Case for Quality'는 품질 관리 관행 개선과 파트너십 구축에 중점을 두고 있습니다. Kindeva Drug Delivery와 Meridian Medical Technologies의 합병 및 2025년 통합은 비경구 및 흡입 제품 생산 능력의 강화를 반영합니다. 한편, Regeneron은 유전자 치료 벡터 개발 및 지속형 혈당 모니터(CGM) 개발 이니셔티브를 기반으로 사업 활동을 지속적으로 확장하고 있습니다. 또한, Apiject와의 제휴를 통해 Brookhaven 시설의 BFS(Blow Fill Seal) 유닛을 확장할 수 있게 되었으며, 동시에 무균 제제 및 HCP CCC 제품 라인을 확장하고 있습니다. 이 분야는 숙련된 인력, 연구개발에 대한 인센티브 등 많은 강점을 가지고 있으며, 시설의 50% 이상이 재생가능 에너지원을 사용하고 있어 탄소발자국을 30%까지 줄일 수 있습니다. 자막 기술과 전략적 투자가 결합하여 첨단 약물 전달 아웃소싱을 위한 독특한 환경을 조성하고 있습니다. 따라서 미국은 첨단 기술과 전략적 투자를 통해 첨단 약물 전달 아웃소싱 분야의 세계 리더가 될 수 있는 좋은 위치에 있습니다.

According to our new research study on "Drug Delivery Devices Contract Manufacturing Market Forecast to 2031 -Global Analysis - by Device Type, Service Type, and Geography," the market is anticipated to grow from US$ 8.24 billion in 2025 to US$ 21.72 billion by 2034, with a CAGR of 11.5% during 2026-2034. The drug delivery devices contract manufacturing market growth is attributed to the increasing prevalence of chronic diseases, technological advancements and innovation, and cost efficiencies through outsourcing.

Outsourcing the design, development and production of drug delivery devices to Contract Development and Manufacturing Organizations (CDMOs) that specialize in these areas means that pharmaceutical and biotechnology companies can concentrate on their core competencies of drug development, research and development and commercialization while benefiting from the experience, expertise, technological capabilities and scale provided by third party manufacturers who manage complete end-to-end production processes. These include fabrication of components, assembly, quality assurance, testing, regulatory compliance, and packaging. Adoption of AI and digital technologies in manufacturing, emphasis on sustainable and eco-friendly manufacturing practices, and the rise of personalized and patient-centric delivery systems are expected to emerge as major drug delivery devices contract manufacturing market trends in the coming years.

The drug delivery devices contract manufacturing market in North America is segmented into the US, Canada, and Mexico. The North America drug delivery devices contract manufacturing market is expanding as the region hosts numerous facilities, with the US alone featuring over 400 specialized sites focused on class II and III devices, emphasizing precision engineering and regulatory compliance. The US holds the largest market share, followed by Canada.

In the United States alone, there are more than 400 specialized facilities that specialize in producing class II and class III medical devices with a focus on engineering precision, regulatory compliance, and developing new technologies for injectables, inhalers and transdermal delivery systems. Leading companies such as Catalent operate multiple facilities for assembling autoinjectors and pen injectors. Integer Holdings Corporation provides the assembly for infusion pumps, allowing them to quickly ramp up production to meet the needs of customers who require high volumes. According to recently released data from the Centers for Disease Control and Prevention (CDC), outsourcing of cardiovascular and orthopaedic delivery devices is projected to grow at an annualized rate of 11.4% until 2020, primarily due to increased rates of diabetes amongst adult Americans (34+ million). The total number of people working in medical device manufacturing exceeds 1 million; improvements in automation have led to a reduction of the defect rate by 20%.

Disruption in the Supply Chain resulted in a 15 % Impact to Time to Market caused by methods employed by the Case for Quality (CfQ) initiative through the FDA - Case for Quality is focused on improving quality practices and building partnerships. The Merger between Kindeva Drug Delivery and Meridian Medical Technologies and their merger in 2025 reflects the increased capacity to create parenteral and inhalation products. Conversely, Regeneron continues to expand its business activities based on Gene Therapy Vector development and Continuous Glucose Monitor (CGM) development initiatives. Additionally, our relationships with Apiject allow us to scale our Blow-Fill-Seal units at our Brookhaven facilities while simultaneously growing our line of sterile dosage forms and HCP CCC's. Our Sector has many attributes, including Skilled Workforce, Research & Development Incentives and over 50% of our Facilities utilize Renewable Energy Sources, which results in reducing our carbon footprint by 30%. Subtitle Technologies, along with Strategic Investments, create a unique environment for Advanced Drug Delivery Outsourcing. Therefore, the United States is well-positioned to be a Global Leader in Advanced Drug Delivery Outsourcing due to its advanced Technology and Strategic Investments.

The US Food and Drug Administration, World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization) are among the primary and secondary sources referred to while preparing the drug delivery devices contract manufacturing market report.

1. Executive Summary

1.1 Analyst Market Outlook
1.2 Market Attractiveness

2. Drug Delivery Devices Contract Manufacturing Market Landscape

2.1 Overview
2.2 Value Chain Analysis
- 2.2.1 Raw Material Suppliers / Components
- 2.2.2 Manufacturers/ Process / Technology
- 2.2.3 Distribution Landscape
- 2.2.4 End User
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Force Analysis
2.5 PEST Analysis
2.6 Impact of Artificial Intelligence (AI)
2.7 Product or Technology Roadmap
2.8 Sustainability and ESG Trends
- 2.8.1 Environmental Trends
- 2.8.2 Social Trends
- 2.8.3 Governance Trends
2.9 Regulatory Framework

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Concentration

4. Drug Delivery Devices Contract Manufacturing Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Chronic Diseases
- 4.1.2 Technological Advancements and Innovation
- 4.1.3 Cost Efficiencies Through Outsourcing
4.2 Market Restraints
- 4.2.1 Stringent Regulatory Requirements
- 4.2.2 Supply Chain Vulnerabilities
- 4.2.3 Quality Assurance and Manufacturing Complexities
4.3 Market Opportunities
- 4.3.1 Expansion into Emerging Markets
- 4.3.2 Integration of AI and IoT
- 4.3.3 Adoption of Sustainable Manufacturing Practices
4.4 Future Trends
- 4.4.1 Adoption of AI and Digital Technologies in Manufacturing
- 4.4.2 Emphasis on Sustainable and Eco-Friendly Manufacturing Practices
- 4.4.3 Rise of Personalized and Patient-Centric Delivery Systems
4.5 Impact of Drivers and Restraints

5. Drug Delivery Devices Contract Manufacturing Market - Global Market Analysis

5.1 Drug Delivery Devices Contract Manufacturing Market Revenue (US$ Million), 2021-2034
5.2 Drug Delivery Devices Contract Manufacturing Market Forecast and Analysis

6. Drug Delivery Devices Contract Manufacturing Market Revenue Analysis -Service Type

6.1 Drug Delivery Devices Contract Manufacturing Market Forecasts and Analysis by Service Type
- 6.1.1 Full-device Manufacturing
  - 6.1.1.1 Overview
  - 6.1.1.2 Full-device Manufacturing: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 6.1.2 Sub-assembly and Components
  - 6.1.2.1 Overview
  - 6.1.2.2 Sub-assembly and Components: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 6.1.3 Materials-specific Services
  - 6.1.3.1 Overview
  - 6.1.3.2 Materials-specific Services: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)

7. Drug Delivery Devices Contract Manufacturing Market Revenue Analysis -Device Type

7.1 Drug Delivery Devices Contract Manufacturing Market Forecasts and Analysis by Device Type
- 7.1.1 Infusion Devices and Administration Set
  - 7.1.1.1 Overview
  - 7.1.1.2 Infusion Devices and Administration Set: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 7.1.2 Syringes
  - 7.1.2.1 Overview
  - 7.1.2.2 Syringes: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 7.1.3 Inhalers
  - 7.1.3.1 Overview
  - 7.1.3.2 Inhalers: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)
- 7.1.4 Autoinjectors and Pen Injectors
  - 7.1.4.1 Overview
  - 7.1.4.2 Autoinjectors and Pen Injectors: Drug Delivery Devices Contract Manufacturing Market -Revenue, 2021-2034 (US$ Million)

8. Drug Delivery Devices Contract Manufacturing Market - Geographical Analysis

8.1 North America
- 8.1.1 North America Drug Delivery Devices Contract Manufacturing Market Overview
- 8.1.2 North America: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.1.3 North America: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.1.3.1 Service Type
  - 8.1.3.2 Device Type
- 8.1.4 North America: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.1.4.1 United States Market
    - 8.1.4.1.1 United States: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.1.4.1.2 United States: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.1.4.1.2.1 Service Type
      - 8.1.4.1.2.2 Device Type
  - 8.1.4.2 Canada Market
    - 8.1.4.2.1 Canada: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.1.4.2.2 Canada: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.1.4.2.2.1 Service Type
      - 8.1.4.2.2.2 Device Type
  - 8.1.4.3 Mexico Market
    - 8.1.4.3.1 Mexico: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.1.4.3.2 Mexico: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.1.4.3.2.1 Service Type
      - 8.1.4.3.2.2 Device Type
8.2 Europe
- 8.2.1 Europe Drug Delivery Devices Contract Manufacturing Market Overview
- 8.2.2 Europe: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.3 Europe: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.2.3.1 Service Type
  - 8.2.3.2 Device Type
- 8.2.4 Europe: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.2.4.1 Germany Market
    - 8.2.4.1.1 Germany: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.1.2 Germany: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.1.2.1 Service Type
      - 8.2.4.1.2.2 Device Type
  - 8.2.4.2 United Kingdom Market
    - 8.2.4.2.1 United Kingdom: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.2.2 United Kingdom: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.2.2.1 Service Type
      - 8.2.4.2.2.2 Device Type
  - 8.2.4.3 France Market
    - 8.2.4.3.1 France: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.3.2 France: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.3.2.1 Service Type
      - 8.2.4.3.2.2 Device Type
  - 8.2.4.4 Italy Market
    - 8.2.4.4.1 Italy: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.4.2 Italy: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.4.2.1 Service Type
      - 8.2.4.4.2.2 Device Type
  - 8.2.4.5 Spain Market
    - 8.2.4.5.1 Spain: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.5.2 Spain: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.5.2.1 Service Type
      - 8.2.4.5.2.2 Device Type
  - 8.2.4.6 Rest of Europe Market
    - 8.2.4.6.1 Rest of Europe: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.6.2 Rest of Europe: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.2.4.6.2.1 Service Type
      - 8.2.4.6.2.2 Device Type
8.3 Asia Pacific
- 8.3.1 Asia Pacific Drug Delivery Devices Contract Manufacturing Market Overview
- 8.3.2 Asia Pacific: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.3 Asia Pacific: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.3.3.1 Service Type
  - 8.3.3.2 Device Type
- 8.3.4 Asia Pacific: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.3.4.1 China Market
    - 8.3.4.1.1 China: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.1.2 China: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.1.2.1 Service Type
      - 8.3.4.1.2.2 Device Type
  - 8.3.4.2 Japan Market
    - 8.3.4.2.1 Japan: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.2.2 Japan: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.2.2.1 Service Type
      - 8.3.4.2.2.2 Device Type
  - 8.3.4.3 India Market
    - 8.3.4.3.1 India: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.3.2 India: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.3.2.1 Service Type
      - 8.3.4.3.2.2 Device Type
  - 8.3.4.4 Australia Market
    - 8.3.4.4.1 Australia: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.4.2 Australia: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.4.2.1 Service Type
      - 8.3.4.4.2.2 Device Type
  - 8.3.4.5 South Korea Market
    - 8.3.4.5.1 South Korea: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.5.2 South Korea: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.5.2.1 Service Type
      - 8.3.4.5.2.2 Device Type
  - 8.3.4.6 Rest of APAC Market
    - 8.3.4.6.1 Rest of APAC: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.6.2 Rest of APAC: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.3.4.6.2.1 Service Type
      - 8.3.4.6.2.2 Device Type
8.4 Middle East and Africa
- 8.4.1 Middle East and Africa Drug Delivery Devices Contract Manufacturing Market Overview
- 8.4.2 Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.4.3 Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.4.3.1 Service Type
  - 8.4.3.2 Device Type
- 8.4.4 Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.4.4.1 Saudi Arabia Market
    - 8.4.4.1.1 Saudi Arabia: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.1.2 Saudi Arabia: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.4.4.1.2.1 Service Type
      - 8.4.4.1.2.2 Device Type
  - 8.4.4.2 South Africa Market
    - 8.4.4.2.1 South Africa: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.2.2 South Africa: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.4.4.2.2.1 Service Type
      - 8.4.4.2.2.2 Device Type
  - 8.4.4.3 United Arab Emirates Market
    - 8.4.4.3.1 United Arab Emirates: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.3.2 United Arab Emirates: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.4.4.3.2.1 Service Type
      - 8.4.4.3.2.2 Device Type
  - 8.4.4.4 Rest of Middle East and Africa Market
    - 8.4.4.4.1 Rest of Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.4.2 Rest of Middle East and Africa: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.4.4.4.2.1 Service Type
      - 8.4.4.4.2.2 Device Type
8.5 South and Central America
- 8.5.1 South and Central America Drug Delivery Devices Contract Manufacturing Market Overview
- 8.5.2 South and Central America: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.5.3 South and Central America: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
  - 8.5.3.1 Service Type
  - 8.5.3.2 Device Type
- 8.5.4 South and Central America: Drug Delivery Devices Contract Manufacturing Market Breakdown by Countries
  - 8.5.4.1 Brazil Market
    - 8.5.4.1.1 Brazil: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.5.4.1.2 Brazil: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.5.4.1.2.1 Service Type
      - 8.5.4.1.2.2 Device Type
  - 8.5.4.2 Argentina Market
    - 8.5.4.2.1 Argentina: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.5.4.2.2 Argentina: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.5.4.2.2.1 Service Type
      - 8.5.4.2.2.2 Device Type
  - 8.5.4.3 Rest of South and Central America Market
    - 8.5.4.3.1 Rest of South and Central America: Drug Delivery Devices Contract Manufacturing Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.5.4.3.2 Rest of South and Central America: Drug Delivery Devices Contract Manufacturing Market- By Segmentation
      - 8.5.4.3.2.1 Service Type
      - 8.5.4.3.2.2 Device Type

9. Drug Delivery Devices Contract Manufacturing Market Industry Landscape

10. Drug Delivery Devices Contract Manufacturing Market - Key Company Profiles

10.1 MICRO
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Freudenberg Group
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Flex Ltd
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Jabil Inc
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 SMC Ltd
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 TE Connectivity Ltd
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Heraeus Group
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Cirtec Medical Corp
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Integer Holdings Corp
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Tegra Medical
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. Appendix

11.1 Glossary
11.2 Research Methodology and Approach
- 11.2.1 Secondary Research
- 11.2.2 Primary Research
- 11.2.3 Market Estimation Approach
  - 11.2.3.1 Supply Side Analysis
  - 11.2.3.2 Demand Side Analysis
- 11.2.4 Research Assumptions and Limitations
- 11.2.5 Currency Conversion
11.3 About The Insight Partners
11.4 Market Intelligence Cloud

약물전달 기기 수탁제조 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 범위 - 디바이스 유형별, 서비스 유형별, 지역별

Drug Delivery Devices Contract Manufacturing Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Device Type, Service Type, and Geography

목차

제1장 주요 요약

제2장 약물전달 기기 수탁제조 시장 구도

제3장 경쟁 구도

제4장 약물전달 기기 수탁제조 시장 - 주요 시장 역학

제5장 약물전달 기기 수탁제조 시장 - 세계 시장 분석

제6장 약물전달 기기 수탁제조 시장 매출 분석 - 서비스 유형별

제7장 약물전달 기기 수탁제조 시장 매출 분석 - 디바이스 유형별

제8장 약물전달 기기 수탁제조 시장 - 지역 분석

제9장 약물전달 기기 수탁제조 시장 상황

제10장 약물전달 기기 수탁제조 시장 - 주요 기업 개요

제11장 부록

Table Of Contents